Drugs / DC-Tn-MUC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00852007 | Feb 2009 → Feb 2014 | prostate cancer | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC-Tn-MUC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00852007 ↗ |
| Modality | Cell therapy | “autologous dendritic cells” NCT00852007 ↗ |